股本结构
单位：万股
| 公告日期 | 2023-11-14 | 2023-11-08 | 2023-11-08 | 2023-11-14 | 2023-09-22 | 2023-09-22 |
|---|---|---|---|---|---|---|
| 证券总股本 | 939.79 | 1110.81 | 939.79 | 880.53 | 880.53 | 4402.64 |
| 普通股本 | 939.79 | 1110.81 | 939.79 | 880.53 | 880.53 | 4402.64 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-11-10 | 2023-11-06 | 2023-10-20 | 2023-09-30 | 2023-09-25 | 2023-09-22 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2023-11-14 | 939.79 | 未披露 | 定期报告 | 2023-11-10 |
| 2023-11-08 | 1110.81 | 未披露 | 定期报告 | 2023-11-06 |
| 2023-11-08 | 939.79 | 未披露 | 定期报告 | 2023-10-20 |
| 2023-11-14 | 880.53 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Shares issued upon vesting of restricted stock units
|
2023-09-30 |
| 2023-09-22 | 880.53 | 未披露 |
更多>>
Board of Directors has approved a reverse stock split of the Company’s outstanding shares of common stock at a ratio of 1-for-5. The reverse stock split will become effective at 12:01 a.m. Eastern time on September 25, 2023.
|
2023-09-25 |
| 2023-09-22 | 4402.64 | 未披露 | 定期报告 | 2023-09-22 |
| 2023-08-10 | 4402.14 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Shares issued upon the exercise of pre-funded warrants
Issuance of shares under Employee Stock Purchase Plan
Shares issued upon vesting of restricted stock units
|
2023-06-30 |
| 2023-04-27 | 4282.83 | 未披露 | 定期报告 | 2023-04-20 |
| 2023-05-08 | 4281.83 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Shares issued upon vesting of restricted stock units
|
2023-03-31 |
| 2023-03-20 | 4281.83 | 未披露 | 定期报告 | 2023-03-16 |
| 2023-03-20 | 4264.83 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Common stock issued upon vesting of restricted stock units
Common stock issued upon exercises of stock options
Issuance of common stock under Employee Stock Purchase Plan
|
2022-12-31 |
| 2022-11-14 | 4259.46 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Shares issued upon vesting of restricted stock units
|
2022-09-30 |
| 2022-08-09 | 4257.99 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of shares under Employee Stock Purchase Plan
Shares issued upon vesting of restricted stock units
|
2022-06-30 |
| 2022-05-09 | 4250.40 | 未披露 | 定期报告 | 2022-05-05 |
| 2022-05-09 | 4249.40 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Shares issued upon exercises of stock options
|
2022-03-31 |
| 2022-03-01 | 4249.40 | 未披露 | 定期报告 | 2022-02-28 |
| 2022-03-01 | 4245.75 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Common stock issued upon exercises of stock options
Common stock issued upon vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
|
2021-12-31 |
| 2021-11-04 | 4242.81 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Shares issued upon exercises of stock options
Shares issued upon vesting of restricted stock units
|
2021-09-30 |
| 2021-08-05 | 4242.51 | 未披露 | 定期报告 | 2021-08-03 |
| 2021-08-05 | 4241.91 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Shares issued upon exercises of stock options
Issuance of shares under Employee Stock Purchase Plan
Shares issued upon vesting of restricted stock units
|
2021-06-30 |
| 2021-05-12 | 4234.57 | 未披露 | 定期报告 | 2021-05-10 |
| 2021-05-12 | 4232.60 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Shares issued upon exercises of stock options
Shares issued upon vesting of restricted stock units
|
2021-03-31 |
| 2021-03-25 | 4232.60 | 未披露 | 定期报告 | 2021-03-22 |
| 2021-03-31 | 4229.60 | 未披露 | 定期报告 | 2021-03-18 |
| 2021-03-25 | 4219.63 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock and pre-funded warrants, net of discounts, commissions and offering expenses of $4,930
Options exercised
Restricted stock units vested
Issuance of common stock under Employee Stock Purchase Plan
|
2020-12-31 |
| 2020-12-11 | 4193.48 | 未披露 | 定期报告 | 2020-12-10 |
| 2020-11-09 | 4189.44 | 未披露 | 定期报告 | 2020-11-04 |
| 2020-11-09 | 4187.66 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock and pre-funded warrants,net of commissions and offering expenses
Options exercised
Restricted stock units vested
|
2020-09-30 |
| 2020-08-12 | 4174.90 | 未披露 | 定期报告 | 2020-08-07 |
| 2020-07-07 | 4164.86 | 未披露 |
更多>>
1.Common Stock Offered by the company 3,262,471 shares
2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 38,386,160 shares of common stock outstanding as of March 31, 2020
|
2020-07-07 |
| 2020-08-12 | 3848.65 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Restricted stock units vested
Options exercised
|
2020-06-30 |
| 2020-05-06 | 3848.50 | 未披露 | 定期报告 | 2020-05-04 |
| 2020-05-06 | 3838.62 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Restricted stock units vested
Options exercised
|
2020-03-31 |
| 2020-03-12 | 3837.32 | 未披露 | 定期报告 | 2020-03-12 |
| 2020-03-12 | 3799.68 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of common stock for Former Neoleukin common stock
Conversion of convertible preferred stock into common shares
Issuance of common stock, net of share issuance costs of $5,525
Issuance of shares to University of Washington
Conversion of common stock to pre-funded warrants
Options exercised
|
2019-12-31 |
| 2019-12-20 | 4728.42 | 未披露 | 定期报告 | 2019-12-20 |
| 2019-12-17 | 3835.92 | 未披露 | 定期报告 | 2019-11-30 |
| 2019-11-13 | 3833.29 | 未披露 | 定期报告 | 2019-11-13 |
| 2019-11-13 | 2814.02 | 10.19 |
更多>>
From June 30, 2019 to September 30, 2019
Issuance of common stock for Former Neoleukin common stock
Options exercised
|
2019-09-30 |
| 2019-10-02 | 2813.56 | 未披露 | 定期报告 | 2019-09-18 |
| 2019-03-07 | 2353.74 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Options exercised
|
2018-12-31 |
| 2018-08-08 | 2353.74 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-08 | 2350.82 | 未披露 | 定期报告 | 2018-05-08 |
| 2018-05-08 | 2349.22 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-12 | 2349.09 | 未披露 | 定期报告 | 2018-03-09 |
| 2018-03-26 | 2347.47 | 未披露 | 定期报告 | 2018-01-31 |
| 2018-03-12 | 2347.24 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Options exercised
|
2017-12-31 |
| 2017-11-08 | 2346.49 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-08 | 2346.47 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-03-09 | 2342.32 | 未披露 |
更多>>
From December 31, 2015 to September 30, 2016
Issuance of Aquinox common stock, net of share issuance costs of $4,692
Options exercised
Exercise of warrants
|
2016-09-30 |
| 2016-08-04 | 1721.26 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-03-14 | 1721.20 | 未披露 |
更多>>
from December 31, 2014 to December 18, 2015
Issuance of Aquinox common stock, net of share issuance costs of $6,245
Options exercised
|
2015-12-18 |
| 2015-11-10 | 1721.20 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-06 | 1072.72 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-04-01 | 1072.31 | 未披露 | 定期报告 | 2015-03-27 |
| 2015-03-16 | 1071.71 | 未披露 | 定期报告 | 2015-03-12 |
| 2015-03-16 | 1069.51 | 未披露 |
更多>>
from December 31, 2013 to September 30, 2014
Conversion of preferred stock into Aquinox USA common stock
Issuance of Aquinox common stock, net of share issuance costs of $5,838,726
Issuance of Aquinox common stock, on purchase of patent rights
Options exercised
A 1-for-19.2 reverse stock split of Aquinox USA’s common stock and convertible preferred stock and AQXP Canada’s common exchangeable shares and exchangeable preferred shares that was effected on February 27, 2014
|
2014-09-30 |
| 2014-08-11 | 1069.50 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-05-13 | 1067.53 | 未披露 |
更多>>
from March 12, 2014 to March 31, 2014
Conversion of preferred stock into Aquinox USA common stock
Issuance of Aquinox common stock, net of share issuance costs of $5,788,726
|
2014-03-31 |
| 2014-03-07 | 1004.53 | 未披露 |
更多>>
A 1-for-19.2 reverse stock split of Aquinox USA’s common stock and convertible preferred stock and AQXP Canada’s common exchangeable shares and exchangeable preferred shares that was effected on February 27, 2014
The conversion of all of the outstanding shares of our convertible preferred stock (including the 1,963,419 shares of our convertible preferred stock issuable upon the exchange of all of the outstanding exchangeable preferred shares of AQXP Canada) into an aggregate of 5,543,515 shares of our common stock, which will occur immediately prior to the completion of this offering
|
2014-03-07 |
| 2014-01-28 | 4349.17 | 6873.81 |
更多>>
from December 31, 2012 to December 31, 2013
Issued for cash, net of share issue costs
Warrants exercised
|
2013-12-31 |
From June 30, 2023 to September 30, 2023
Shares issued upon vesting of restricted stock units
Board of Directors has approved a reverse stock split of the Company’s outstanding shares of common stock at a ratio of 1-for-5. The reverse stock split will become effective at 12:01 a.m. Eastern time on September 25, 2023.
From March 31, 2023 to June 30, 2023
Shares issued upon the exercise of pre-funded warrants
Issuance of shares under Employee Stock Purchase Plan
Shares issued upon vesting of restricted stock units
From December 31, 2022 to March 31, 2023
Shares issued upon vesting of restricted stock units
From December 31, 2021 to December 31, 2022
Common stock issued upon vesting of restricted stock units
Common stock issued upon exercises of stock options
Issuance of common stock under Employee Stock Purchase Plan
From June 30, 2022 to September 30, 2022
Shares issued upon vesting of restricted stock units
From March 31, 2022 to June 30, 2022
Issuance of shares under Employee Stock Purchase Plan
Shares issued upon vesting of restricted stock units
From December 31, 2021 to March 31, 2022
Shares issued upon exercises of stock options
From December 31, 2020 to December 31, 2021
Common stock issued upon exercises of stock options
Common stock issued upon vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
From June 30, 2021 to September 30, 2021
Shares issued upon exercises of stock options
Shares issued upon vesting of restricted stock units
From March 31, 2021 to June 30, 2021
Shares issued upon exercises of stock options
Issuance of shares under Employee Stock Purchase Plan
Shares issued upon vesting of restricted stock units
From December 31, 2020 to March 31, 2021
Shares issued upon exercises of stock options
Shares issued upon vesting of restricted stock units
From December 31, 2019 to December 31, 2020
Issuance of common stock and pre-funded warrants, net of discounts, commissions and offering expenses of $4,930
Options exercised
Restricted stock units vested
Issuance of common stock under Employee Stock Purchase Plan
From June 30, 2020 to September 30, 2020
Issuance of common stock and pre-funded warrants,net of commissions and offering expenses
Options exercised
Restricted stock units vested
1.Common Stock Offered by the company 3,262,471 shares
2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 38,386,160 shares of common stock outstanding as of March 31, 2020
From March 31, 2020 to June 30, 2020
Restricted stock units vested
Options exercised
From December 31, 2019 to March 31, 2020
Restricted stock units vested
Options exercised
From December 31, 2018 to December 31, 2019
Issuance of common stock for Former Neoleukin common stock
Conversion of convertible preferred stock into common shares
Issuance of common stock, net of share issuance costs of $5,525
Issuance of shares to University of Washington
Conversion of common stock to pre-funded warrants
Options exercised
From June 30, 2019 to September 30, 2019
Issuance of common stock for Former Neoleukin common stock
Options exercised
from December 31, 2017 to December 31, 2018
Options exercised
from December 31, 2016 to December 31, 2017
Options exercised
From December 31, 2015 to September 30, 2016
Issuance of Aquinox common stock, net of share issuance costs of $4,692
Options exercised
Exercise of warrants
from December 31, 2014 to December 18, 2015
Issuance of Aquinox common stock, net of share issuance costs of $6,245
Options exercised
from December 31, 2013 to September 30, 2014
Conversion of preferred stock into Aquinox USA common stock
Issuance of Aquinox common stock, net of share issuance costs of $5,838,726
Issuance of Aquinox common stock, on purchase of patent rights
Options exercised
A 1-for-19.2 reverse stock split of Aquinox USA’s common stock and convertible preferred stock and AQXP Canada’s common exchangeable shares and exchangeable preferred shares that was effected on February 27, 2014
from March 12, 2014 to March 31, 2014
Conversion of preferred stock into Aquinox USA common stock
Issuance of Aquinox common stock, net of share issuance costs of $5,788,726
A 1-for-19.2 reverse stock split of Aquinox USA’s common stock and convertible preferred stock and AQXP Canada’s common exchangeable shares and exchangeable preferred shares that was effected on February 27, 2014
The conversion of all of the outstanding shares of our convertible preferred stock (including the 1,963,419 shares of our convertible preferred stock issuable upon the exchange of all of the outstanding exchangeable preferred shares of AQXP Canada) into an aggregate of 5,543,515 shares of our common stock, which will occur immediately prior to the completion of this offering
from December 31, 2012 to December 31, 2013
Issued for cash, net of share issue costs
Warrants exercised